Exploratory Clinical Neuroscience Research on Substance Use Disorders

$915K USD

Funder	National Institutes of Health
Recipient Organization	Not specified
Country	USA
Start Date	Mar 16, 2026
End Date	Jul 26, 2032
Duration	2,324 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`42df9ed2-0331-41fd-8d9b-6040ec13e4c9`

Grant Description

This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This NOFO is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)